August 21, 2020
Nippon Shinyaku said on August 20 that it has rolled out its Duchenne muscular dystrophy (DMD) treatment Viltepso (viltolarsen) in the US following its accelerated approval earlier this month. The drug hit the market on August 19 for the treatment...read more